Trial intelligence / Profile preview

Discontinuation of antihypertensive treatment in nursing home residents with dementia

NL-OMON50258Active, not recruiting

Sponsor
Leiden University Medical Center
Start
Nov 2018
Countries
1
01

Overview

Randomised, open-label trial in Dementia (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Change in Neuropsychiatric Inventory - Nursing Homes score and Change in quality of life (Qualidem). Started Nov 2018; status: active, not recruiting.

02

Conditions

Dementia

Beyond the preview

Go deeper on NL-OMON50258.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON50258.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call